Final analysis of the multicenter phase II "Bologna 2002" study incorporating thalidomide-dexamethasone (thal-dex) into up-front double autologous stem-cell transplantation (ASCT) for multiple myeloma
Elena Zamagni(Istituti di Ricovero e Cura a Carattere Scientifico), Michèle Cavo(Unknown), Giulia Perrone(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Fabrizio Patriarca, Mauro Fiacchini(Istituto di Ematologia di Bologna), Annamaria Brioli(Universitätsmedizin Greifswald), Alessandro Gozzetti(University of Siena), Francesco Di Raimondo(University of Catania), Chiara Nicci(Istituto di Ematologia di Bologna), Carolina Terragna(Fondazione Gimema Onlus), Lucia Pantani(Istituto di Ematologia di Bologna), M Baccarini, Alessandro Petrucci, Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Lucio Catalano(University of Naples Federico II), Sadia Falcioni, Matteo Renzulli(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Catello Califano(Presidio Ospedaliero), Michela Ceccolini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Christina Cellini, P Tachetti, A Carubbelli, A Ledda(University of Bologna), Luciano Masini(Casa di Cura Villa Garda), P. Tosi(Orthopaedic Research Foundation), Sara Volpe
Unknown
January 1, 2009
Cited by 0
Related Papers
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
|Leukemia|2011|721
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719